doi: 10.1073/pnas.1710540114 207 FosterJDVaughanRA
Your APP will review your medical and surgical history with you
Anyhow, I got an IV during my visit for hydration and the PCP was attentive to my concerns and took care of me.roseofsheryn RoseTrustindex verifies that the original source of the review is Google.I have health conditions that keep me dehydrated if I do not get regular IVs
Study design Population-based, propensity scorematched cohort 173,846 patients total (86,923 per cohort) Mean age: 56.9 12.7 years 52.0% women Comparison: tirzepatide initiation vs lifestyle intervention alone (no weight-loss drug exposure) Key outcomes at 12 months Tirzepatide use was associated with a lower risk of incident and progressive diabetic retinopathy, including reduced need for ocular interventions: Incident mild NPDR: RR 0.864 (95% CI 0.7580.985) Proliferative DR: RR 0.705 (0.5640.882) DR with macular edema: RR 0.624 (0.5360.727) Vitreous hemorrhage: RR 0.607 (0.4290.860) Tractional retinal detachment: RR 0.370 (0.1790.765) Intravitreal anti-VEGF injections: RR 0.479 (0.3680.625) Pan-retinal photocoagulation: RR 0.610 (0.4030.924) Why this matters As tirzepatide continues to reshape cardiometabolic care, these findings add meaningful real-world evidence suggesting not only metabolic benefit, but a potential reduction in microvascular complications, including those requiring procedural intervention
( Brand names require a prescription ) 34 years of medical weight loss experience 15 clinics across MD & VA 4.9 from 2,700+ reviews One pathway
Introduction The World Health Organization (WHO) defines obesity as an abnormal fat accumulation that may impair health ( The short-chain fatty acids (SCFAs) are ingested through diet or produced by fermentation of non-digestible fiber by gut microbiota
.png.jpg)
